TY - JOUR
KW -  neglected tropical diseases
KW - coronavirus
KW - modeling
KW - Covid-19
AU - Toor J
AU - Adams E
AU - Aliee M
AU - Amoah B
AU - Anderson RM
AU - Ayabina D
AU - Bailey R
AU - Basáñez M
AU - Blok D
AU - Blumberg S
AU - Borlase A
AU - Rivera R
AU - Castaño M
AU - Chitnis N
AU - Coffeng L
AU - Crump R
AU - Das A
AU - Davis CN
AU - Davis E
AU - Deiner M
AU - Diggle PJ
AU - Fronterrè C
AU - Giardina F
AU - Giorgi E
AU - Graham M
AU - Hamley J
AU - Huang C
AU - Kura K
AU - Lietman TM
AU - Lucas T
AU - Malizia V
AU - Medley G
AU - Meeyai A
AU - Michael E
AU - Porco TC
AU - Prada J
AU - Rock KS
AU - Le Rutte E
AU - Smith M
AU - Spencer S
AU - Stolk W
AU - Touloupou P
AU - Vasconcelos A
AU - Vegvari C
AU - de Vlas S
AU - Walker M
AU - Hollingsworth DT
AB - <p>Due to the COVID-19 pandemic, many key neglected tropical disease (NTD) activities have been postponed. This hindrance comes at a time when the NTDs are progressing towards their ambitious goals for 2030. Mathematical modelling on several NTDs, namely gambiense sleeping sickness, lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), trachoma, and visceral leishmaniasis, shows that the impact of this disruption will vary across the diseases. Programs face a risk of resurgence, which will be fastest in high-transmission areas. Furthermore, of the mass drug administration diseases, schistosomiasis, STH, and trachoma are likely to encounter faster resurgence. The case-finding diseases (gambiense sleeping sickness and visceral leishmaniasis) are likely to have fewer cases being detected but may face an increasing underlying rate of new infections. However, once programs are able to resume, there are ways to mitigate the impact and accelerate progress towards the 2030 goals.</p>
BT - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
C1 - https://www.ncbi.nlm.nih.gov/pubmed/32984870
DA - 09/2020
DO - 10.1093/cid/ciaa933
J2 - Clin Infect Dis
LA - eng
N2 - <p>Due to the COVID-19 pandemic, many key neglected tropical disease (NTD) activities have been postponed. This hindrance comes at a time when the NTDs are progressing towards their ambitious goals for 2030. Mathematical modelling on several NTDs, namely gambiense sleeping sickness, lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), trachoma, and visceral leishmaniasis, shows that the impact of this disruption will vary across the diseases. Programs face a risk of resurgence, which will be fastest in high-transmission areas. Furthermore, of the mass drug administration diseases, schistosomiasis, STH, and trachoma are likely to encounter faster resurgence. The case-finding diseases (gambiense sleeping sickness and visceral leishmaniasis) are likely to have fewer cases being detected but may face an increasing underlying rate of new infections. However, once programs are able to resume, there are ways to mitigate the impact and accelerate progress towards the 2030 goals.</p>
PY - 2020
T2 - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
TI - Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation.
UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543306/pdf/ciaa933.pdf
SN - 1537-6591
ER -